Company Unknown
CEO allegedly embezzled $3.9M from “a pharmaceutical company” but the DOJ complaint didn't bother mentioning the name of the company. So that’s now a minor detail in an embezzlement case, eh?
AP is saying it's Cambridge Therapeutic Technologies, which is such a big player in the industry we'd never even heard of them. That company was created in May 2016 which is the same month they received $3.9M from a customer that then disappeared from the company accounts. Wow, took them a week to land a $3.9M contract - not shady at all!
Not sure how the company expected to succeed with the "we never got the money" excuse. It's not like this was $4M in cash - it's all tracked by banks. Idiots.
Team Roast
How dedicated is the CEO, Founder & Chairman of SynCoreBio? Judging by his picture, he didn’t even take a day off work for his wedding - just rolled up into the office with the biggest damn boutonniere you’ve ever seen.
"Bust your butt and someday you’ll be wearing a decorated lily pad to work too, kid!"
Name Game
Brain Bits has taken on a new identity. At one time maybe such a literal name for a company selling CNS tissue may have seemed like a good idea, but that day has passed. They will henceforth be Transnetyx, which is a suitably meaningless letter jumble for a modern biotech company. 6/10
Website Roast
This company knows science…like, hello, there’s a picture of a microscope right there on the main page. And some 96-well plates. And an incubator. Aaaaand that’s the whole website.
SCIENCE!!!!
Embecta
Becton Dickinson (BD) decided to spin out its diabetes care division as its own publicly traded entity. That will happen in a few months, but they already settled on a name: Embecta.
It sounds life-sciency. It pays homage to Becton Dickinson. It’s got a logo that looks like an angry eyeball. For once the million dollars in branding consultancy fees was well spent. 8/10
Efficient Markets
We’ve all been taught by our economics textbooks that when two virtually identical products are available, the price should be competed down to near break-even cost. Alas, the American healthcare market is immune to economic theory, especially considering it's got some mad collusion skillz. Otherwise, how can one explain the price of two major, rapid-acting insulins changing by the exact same amount for 15 out of 16 years.
The system is a scam and we're all marks.
Judgement: Unknown
The torch in this logo is pretty neat, but the double-m is visually troubling. We're torn on this one and can deliver no judgement.
Theranos
Last week, the Holmes-bot finished her 7-day testimony as the final witness in her defense. Including herself, the defense brought three witnesses after the prosecution had brought 29.
The CEO blaming their underlings is always a longshot strategy in a fraud case, but you never know... juries are weird. Closing arguments were scheduled to start today.
BioPharmGuy Roast
Last week we put out a call to roast one of the old versions of our website. To jog your memory, here’s that gem: BioPharmGuy 2K9. And here's what you served up:
“A simple site"? Bit redundant for anyone with eyes, no?
Zing.
…one can easily understand why BPG chose the pills as their logo. I can't remember the last time I swallowed a square pill outside of maybe accidentally aspirating a Chiclet during a high school fit of laughter. But then again, I’m not the one taking generic Vi**ra purchased over the border.
Square pills – good call, but that sure took a personal turn.
It isn't bad. It's simple, functional, and unassuming. Nothing to write home about. Nobody should say anything bad about it. Most people won't even notice it.
Had us worried, nice finish.
Please tell me the "Big Site Update" is about a future update...
*sigh*
Nothing screams ‘credible career advice’ quite like a grainy photo of a man in a graphic t-shirt standing next to an unidentifiable yet obviously cluttered object.
All in all, a pretty good showing. Thanks to everyone who sent one in!
